Protagonist Therapeutics, Inc Total Contract Liability
Protagonist Therapeutics, Inc (PTGX) had Total Contract Liability of $6.30 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-05-05
- 2026-03-31: Contract with Customer, Liability $6.30M.
- 2024-12-31: Contract with Customer, Liability $30.60M.
- 2024-09-30: Contract with Customer, Liability $36.20M.
- 2024-06-30: Contract with Customer, Liability $40.90M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2026-03-31 | $6.30M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $30.60M 10-K · filed 2026-02-25 |
| 2024-09-30 | $36.20M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $40.90M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $45.00M 10-Q · filed 2025-05-06 |
| 2021-12-31 | $1.60M 10-K · filed 2024-02-27 |
| 2017-09-30 | $41.74M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $0.00 10-Q · filed 2017-11-07 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |